Mrinal S. Patnaik
Mayo Clinic in Rochester · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mrinal S. Patnaik as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05549661 · Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap NeoplasmsMayo Clinic · recruiting · Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified · principal investigator
- N/ANCT02958462 · Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyMayo Clinic · recruiting · Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome, Clonal Expansion · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Targeting PLK1 in RAS mutant chronic myelomonocytic leukemiaR01CA272496 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2023 to 2026 · $427,131 awarded in 2026Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:54 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed